Remarkable Progress with Small-Molecule Modulation of TRPC1/4/5 Channels: Implications for Understanding the Channels in Health and Disease

Proteins of the TRPC family can form many homo- and heterotetrameric cation channels permeable to Na+, K+ and Ca2+. In this review, we focus on channels formed by the isoforms TRPC1, TRPC4 and TRPC5. We review evidence for the formation of different TRPC1/4/5 tetramers, give an overview of recently developed small-molecule TRPC1/4/5 activators and inhibitors, highlight examples of biological roles of TRPC1/4/5 channels in different tissues and pathologies, and discuss how high-quality chemical probes of TRPC1/4/5 modulators can be used to understand the involvement of TRPC1/4/5 channels in physiological and pathophysiological processes.

[1]  Marc Freichel,et al.  Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms , 2013, Molecular Pharmacology.

[2]  S. Earley,et al.  Transient receptor potential channels in the vasculature. , 2015, Physiological reviews.

[3]  David E. Clapham,et al.  TRP channels as cellular sensors , 2003, Nature.

[4]  Yuyang Sun,et al.  The TRPC1 Ca2+-permeable channel inhibits exercise-induced protection against high-fat diet-induced obesity and type II diabetes , 2017, The Journal of Biological Chemistry.

[5]  Hussein N. Rubaiy,et al.  Pico145 - powerful new tool for TRPC1/4/5 channels , 2017, Channels.

[6]  Craig Montell,et al.  The TRP Superfamily of Cation Channels , 2005, Science's STKE.

[7]  A. Firth,et al.  TRP channels in hypertension. , 2007, Biochimica et biophysica acta.

[8]  M. Freichel,et al.  Mechanism of Stretch-Induced Activation of the Mechanotransducer Zyxin in Vascular Cells , 2012, Science Signaling.

[9]  D. Armstrong,et al.  Functional interactions among Orai1, TRPCs, and STIM1 suggest a STIM-regulated heteromeric Orai/TRPC model for SOCE/Icrac channels , 2008, Proceedings of the National Academy of Sciences.

[10]  S. Brain,et al.  Correspondence: Challenging a proposed role for TRPC5 in aortic baroreceptor pressure-sensing , 2018, Nature Communications.

[11]  DongXu He,et al.  Transient receptor potential channel C5 in cancer chemoresistance , 2015, Acta Pharmacologica Sinica.

[12]  J. Hampe,et al.  Association Study of TRPC4 as a Candidate Gene for Generalized Epilepsy with Photosensitivity , 2010, NeuroMolecular Medicine.

[13]  D. Julius,et al.  Structure of the TRPV1 ion channel determined by electron cryo-microscopy , 2013, Nature.

[14]  H. Hammes,et al.  TRPC proteins contribute to development of diabetic retinopathy and regulate glyoxalase 1 activity and methylglyoxal accumulation , 2018, Molecular metabolism.

[15]  E. Zamir,et al.  Reverse engineering intracellular biochemical networks. , 2008, Nature chemical biology.

[16]  Francisco Corzana,et al.  Unveiling (−)‐Englerin A as a Modulator of L‐Type Calcium Channels , 2016, Angewandte Chemie.

[17]  M. Schaefer,et al.  A benzothiadiazine derivative and methylprednisolone are novel and selective activators of transient receptor potential canonical 5 (TRPC5) channels. , 2017, Cell calcium.

[18]  D. Walsh,et al.  Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation , 2016, Annals of the rheumatic diseases.

[19]  R. Henderson,et al.  AFM imaging reveals the tetrameric structure of the TRPC1 channel. , 2007, Biochemical and biophysical research communications.

[20]  D. Clapham,et al.  Structure of the mouse TRPC4 ion channel , 2018, Nature Communications.

[21]  Meng Wu,et al.  Identification and optimization of 2‐aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels , 2015, British journal of pharmacology.

[22]  Herbert Waldmann,et al.  Na+ entry through heteromeric TRPC4/C1 channels mediates (−)Englerin A-induced cytotoxicity in synovial sarcoma cells , 2017, Scientific Reports.

[23]  R. Bindels,et al.  Renal physiology: TRPC5 inhibition to treat progressive kidney disease , 2018, Nature Reviews Nephrology.

[24]  P. Rybarczyk,et al.  New insights into pharmacological tools to TR(i)P cancer up , 2014, British journal of pharmacology.

[25]  Xiao-Qiang Li,et al.  Canonical Transient Receptor Potential Channels and Their Link with Cardio/Cerebro-Vascular Diseases , 2017, Biomolecules & therapeutics.

[26]  Chang-Xi Bai,et al.  Formation of a new receptor‐operated channel by heteromeric assembly of TRPP2 and TRPC1 subunits , 2008, EMBO Reports.

[27]  Yufang Tang,et al.  Isoform-specific Inhibition of TRPC4 Channel by Phosphatidylinositol 4,5-Bisphosphate* , 2008, Journal of Biological Chemistry.

[28]  F. Zou,et al.  Upregulation of Transient Receptor Potential Canonical Channels Contributes to Endotoxin-Induced Pulmonary Arterial Stenosis , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[29]  G. Schultz,et al.  Functional Differences between TRPC4 Splice Variants* , 2002, The Journal of Biological Chemistry.

[30]  S. Swedo,et al.  Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder. , 2010, Journal of child and adolescent psychopharmacology.

[31]  John P. Overington,et al.  The promise and peril of chemical probes. , 2015, Nature chemical biology.

[32]  D. O'regan,et al.  Short-Term Stimulation of Calcium-Permeable Transient Receptor Potential Canonical 5-Containing Channels by Oxidized Phospholipids , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[33]  P. Lipp,et al.  A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling. , 2015, European heart journal.

[34]  Joseph P. Yuan,et al.  Canonical transient receptor potential channels in diabetes , 2012, Experimental biology and medicine.

[35]  Stephen V Frye,et al.  The art of the chemical probe. , 2010, Nature chemical biology.

[36]  K. Nicolaou,et al.  Total synthesis of englerin A. , 2010, Journal of the American Chemical Society.

[37]  M. Schaefer,et al.  TRPC4 and TRPC5: receptor-operated Ca2+-permeable nonselective cation channels. , 2003, Cell calcium.

[38]  M. Tominaga,et al.  Nitric oxide activates TRP channels by cysteine S-nitrosylation , 2006, Nature chemical biology.

[39]  Albert S. Yu,et al.  Role of TRP channels in the cardiovascular system. , 2015, American journal of physiology. Heart and circulatory physiology.

[40]  K. Westlund,et al.  A rat knockout model implicates TRPC4 in visceral pain sensation , 2014, Neuroscience.

[41]  Georg Rast,et al.  Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice , 2018, PloS one.

[42]  J. Beutler,et al.  Englerins: A Comprehensive Review. , 2017, Journal of natural products.

[43]  Melissa R. Miller,et al.  Identification of ML204, a Novel Potent Antagonist That Selectively Modulates Native TRPC4/C5 Ion Channels* , 2011, The Journal of Biological Chemistry.

[44]  A. Jeromin,et al.  TRPC1, a human homolog of a Drosophila store-operated channel. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Legido-Quigley,et al.  Transient receptor potential canonical 5 channels plays an essential role in hepatic dyslipidemia associated with cholestasis , 2017, Scientific Reports.

[46]  Juan Du,et al.  Structure of the human lipid-gated cation channel TRPC3 , 2018, eLife.

[47]  Juan Du,et al.  Electron cryo-microscopy structure of a human TRPM4 channel , 2017, Nature.

[48]  S. Barral,et al.  Interaction Between TRPC Channel Subunits in Endothelial Cells , 2006, Journal of receptor and signal transduction research.

[49]  C. L. Morales-Pérez,et al.  X-ray structure of the human α4β2 nicotinic receptor , 2016, Nature.

[50]  Antti Pertovaara,et al.  Regulation of neuropathic pain behavior by amygdaloid TRPC4/C5 channels , 2015, Neuroscience Letters.

[51]  B. Nilius,et al.  Sensing with TRP channels , 2005, Nature chemical biology.

[52]  D. Clapham,et al.  Essential Role for TRPC5 in Amygdala Function and Fear-Related Behavior , 2009, Cell.

[53]  David J Beech,et al.  In pursuit of small molecule chemistry for calcium‐permeable non‐selective TRPC channels – mirage or pot of gold? , 2013, British journal of pharmacology.

[54]  Eric Gouaux,et al.  Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation , 2017, Science.

[55]  T. Stevens,et al.  Transient Receptor Potential Channel 4 Encodes a Vascular Permeability Defect and High-Frequency Ca(2+) Transients in Severe Pulmonary Arterial Hypertension. , 2016, The American journal of pathology.

[56]  Hiro Furukawa,et al.  Crystal structure of a heterotetrameric NMDA receptor ion channel , 2014, Science.

[57]  L. Birnbaumer,et al.  Physiology and pathophysiology of canonical transient receptor potential channels , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  E. Carpenter,et al.  Structure of the polycystic kidney disease TRP channel Polycystin-2 (PC2) , 2016, Nature Structural &Molecular Biology.

[59]  E. Lander,et al.  A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models , 2017, Science.

[60]  Craig Montell,et al.  A unified nomenclature for the superfamily of TRP cation channels. , 2002, Molecular cell.

[61]  P. Emery,et al.  TRPC channel activation by extracellular thioredoxin , 2008, Nature.

[62]  S. Atkin,et al.  TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis. , 2012, Current cancer drug targets.

[63]  M. Schaefer,et al.  Riluzole activates TRPC5 channels independently of PLC activity , 2014, British journal of pharmacology.

[64]  K. Gustafson,et al.  Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri. , 2009, Organic letters.

[65]  Jianhong Luo,et al.  Functional Role of Vanilloid Transient Receptor Potential 4-Canonical Transient Receptor Potential 1 Complex in Flow-Induced Ca2+ Influx , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[66]  L. Neckers,et al.  Synthesis of a stable and orally bioavailable englerin analogue. , 2016, Bioorganic & medicinal chemistry letters.

[67]  D. Julius,et al.  TRPV1 structures in distinct conformations reveal mechanisms of activation , 2013, Nature.

[68]  T. Gudermann,et al.  Subunit composition of mammalian transient receptor potential channels in living cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[69]  L. Vaca,et al.  Regulation of the cellular localization and function of human transient receptor potential channel 1 by other members of the TRPC family. , 2008, Cell calcium.

[70]  William A Weiss,et al.  Recognizing and exploiting differences between RNAi and small-molecule inhibitors. , 2007, Nature chemical biology.

[71]  M. Peyton,et al.  Mouse trp2, the homologue of the human trpc2 pseudogene, encodes mTrp2, a store depletion-activated capacitative Ca2+ entry channel. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Hussein N. Rubaiy,et al.  (−)-Englerin A-evoked Cytotoxicity Is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase* , 2016, The Journal of Biological Chemistry.

[73]  D. Clapham,et al.  Decreased Anxiety-Like Behavior and Gαq/11-Dependent Responses in the Amygdala of Mice Lacking TRPC4 Channels , 2014, The Journal of Neuroscience.

[74]  Jing Li,et al.  Natural and synthetic flavonoid modulation of TRPC5 channels , 2016, British journal of pharmacology.

[75]  Herbert Waldmann,et al.  Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels , 2017, The Journal of Biological Chemistry.

[76]  W. Kühlbrandt.  The Resolution Revolution , 2014, Science.

[77]  D. Clapham,et al.  Structure of the mouse TRPC 4 ion channel 1 2 , 2018 .

[78]  Herbert Waldmann,et al.  (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels. , 2015, Angewandte Chemie.

[79]  Craig W Lindsley,et al.  Inhibition of the TRPC5 ion channel protects the kidney filter. , 2013, The Journal of clinical investigation.

[80]  K. Krause,et al.  Alternative splice variants of hTrp4 differentially interact with the C‐terminal portion of the inositol 1,4,5‐trisphosphate receptors , 2001, FEBS letters.

[81]  B. Nilius,et al.  TRP channels. , 2012, Comprehensive Physiology.

[82]  Wenjun Guo,et al.  Structure of the receptor-activated human TRPC6 and TRPC3 ion channels , 2018, Cell Research.

[83]  Michael Schaefer,et al.  Clemizole Hydrochloride Is a Novel and Potent Inhibitor of Transient Receptor Potential Channel TRPC5 , 2014, Molecular Pharmacology.

[84]  Xuexiang Wang,et al.  TRPC5 Does Not Cause or Aggravate Glomerular Disease. , 2017, Journal of the American Society of Nephrology : JASN.

[85]  Nathan T. Ross,et al.  Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation , 2015, PloS one.

[86]  A. Rozkalne,et al.  Antagonistic Regulation of Actin Dynamics and Cell Motility by TRPC5 and TRPC6 Channels , 2010, Science Signaling.

[87]  Stefan Raunser,et al.  Electron cryo-microscopy structure of the canonical TRPC4 ion channel , 2018, bioRxiv.

[88]  A. Alzoubi,et al.  TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension. , 2013, The American journal of pathology.

[89]  Hui Yang,et al.  Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex , 2017, Journal of Molecular Neuroscience.

[90]  J. Glenn,et al.  The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors. , 2010, The Journal of infectious diseases.

[91]  Structure of the mouse TRPC4 ion channel , 2018, bioRxiv.

[92]  M. Bellingham.  A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade? , 2011, CNS neuroscience & therapeutics.

[93]  D. Hines,et al.  Plasma membrane insertion of TRPC5 channels contributes to the cholinergic plateau potential in hippocampal CA1 pyramidal neurons , 2010, Hippocampus.

[94]  W. Linehan,et al.  Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. , 2013, Cancer cell.

[95]  Esther B. E. Becker,et al.  Functional expression of calcium‐permeable canonical transient receptor potential 4‐containing channels promotes migration of medulloblastoma cells , 2017, The Journal of physiology.

[96]  Jianpeng Ma,et al.  Structure of the full-length Shaker potassium channel Kv1.2 by normal-mode-based X-ray crystallographic refinement , 2010, Proceedings of the National Academy of Sciences.

[97]  Xueming Li,et al.  Cryo-EM Structures of the Human Endolysosomal TRPML3 Channel in Three Distinct States , 2017, Nature Structural & Molecular Biology.

[98]  D. Julius,et al.  TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action , 2016, Nature.

[99]  David J. Beech,et al.  Transient receptor potential canonical 4 and 5 proteins as targets in cancer therapeutics , 2016, European Biophysics Journal.

[100]  Dachun Yang,et al.  Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels , 2009, Journal of cellular and molecular medicine.

[101]  Michael X. Zhu,et al.  Acute Treatment with a Novel TRPC4/C5 Channel Inhibitor Produces Antidepressant and Anxiolytic-Like Effects in Mice , 2015, PloS one.

[102]  W. Guo,et al.  Expression Patterns of TRPC1 in Cortical Lesions from Patients with Focal Cortical Dysplasia , 2015, Journal of Molecular Neuroscience.

[103]  Hussein N. Rubaiy,et al.  Identification of an (−)‐englerin A analogue, which antagonizes (−)‐englerin A at TRPC1/4/5 channels , 2018, British journal of pharmacology.

[104]  M. Kearney,et al.  Constitutively Active TRPC Channels of Adipocytes Confer a Mechanism for Sensing Dietary Fatty Acids and Regulating Adiponectin , 2012, Circulation research.

[105]  Daozhen Chen,et al.  Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance , 2014, Proceedings of the National Academy of Sciences.

[106]  T. Gudermann,et al.  Transient Receptor Potential Channel 1 (TRPC1) Reduces Calcium Permeability in Heteromeric Channel Complexes , 2011, The Journal of Biological Chemistry.

[107]  C. Heckman,et al.  Effect of prolonged riluzole exposure on cultured motoneurons in a mouse model of ALS. , 2012, Journal of neurophysiology.

[108]  W. Yung,et al.  TRPC5 channels participate in pressure-sensing in aortic baroreceptors , 2019 .

[109]  J. Qu,et al.  Lipopolysaccharide potentiates endothelin-1-induced proliferation of pulmonary arterial smooth muscle cells by upregulating TRPC channels. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[110]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[111]  H. Brinkmeier,et al.  Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains , 2006, BMC Genomics.

[112]  Andreas Draguhn,et al.  Heteromeric channels formed by TRPC1, TRPC4 and TRPC5 define hippocampal synaptic transmission and working memory , 2017, The EMBO journal.

[113]  D. Julius,et al.  Structure of the TRPA1 ion channel suggests regulatory mechanisms , 2015, Nature.